Sunesis to Present at Upcoming Investor Conferences
February 24 2015 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Daniel Swisher, Chief Executive Officer and President of Sunesis,
will present at two upcoming investor conferences:
- Cowen & Company 35th Annual Health Care Conference
Tuesday, March 3rd at 11:20 AM Eastern Time The Boston Marriott
Copley Place, Boston
- 27th Annual ROTH Conference
Tuesday, March 10th at 8:00 AM Pacific Time The Ritz Carlton,
Dana Point, CA
Live webcasts of the presentations will be available on the
Sunesis website at http://ir.sunesis.com. Replays of the webcasts
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the potential treatment of solid and hematologic cancers. Sunesis
has built a highly experienced cancer drug development organization
committed to advancing its lead product candidate, vosaroxin, in
multiple indications to improve the lives of people with
cancer.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks of Sunesis
Pharmaceuticals, Inc.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024